SACK1A and familial pancreatic carcinoma: For instance, overexpression of FAM83A markedly facilitated, whereas inhibition of FAM83A decreased, cancer stem cell (CSC)-like features and chemoresistance both in vitro and in an in vivo mouse model of pancreatic cancer (23).